JPWO2022236050A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022236050A5 JPWO2022236050A5 JP2023568469A JP2023568469A JPWO2022236050A5 JP WO2022236050 A5 JPWO2022236050 A5 JP WO2022236050A5 JP 2023568469 A JP2023568469 A JP 2023568469A JP 2023568469 A JP2023568469 A JP 2023568469A JP WO2022236050 A5 JPWO2022236050 A5 JP WO2022236050A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- polypeptide chain
- nos
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163185805P | 2021-05-07 | 2021-05-07 | |
| US63/185,805 | 2021-05-07 | ||
| PCT/US2022/028066 WO2022236050A1 (en) | 2021-05-07 | 2022-05-06 | T cell receptors recognizing c135y, r175h, or m237i mutation in p53 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024517884A JP2024517884A (ja) | 2024-04-23 |
| JP2024517884A5 JP2024517884A5 (https=) | 2025-05-20 |
| JPWO2022236050A5 true JPWO2022236050A5 (https=) | 2025-05-20 |
Family
ID=81851071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568469A Pending JP2024517884A (ja) | 2021-05-07 | 2022-05-06 | ｐ５３におけるＣ１３５Ｙ、Ｒ１７５Ｈ又はＭ２３７Ｉ変異を認識するＴ細胞受容体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240254190A1 (https=) |
| EP (1) | EP4334340A1 (https=) |
| JP (1) | JP2024517884A (https=) |
| KR (1) | KR20240016288A (https=) |
| CN (1) | CN117957245A (https=) |
| AU (1) | AU2022268998A1 (https=) |
| CA (1) | CA3217263A1 (https=) |
| WO (1) | WO2022236050A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3144070A1 (en) | 2019-06-27 | 2020-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors recognizing r175h or y220c mutation in p53 |
| US12195534B2 (en) | 2023-01-06 | 2025-01-14 | Immunocore Limited | Binding molecules |
| WO2024163371A1 (en) * | 2023-01-30 | 2024-08-08 | Fred Hutchinson Cancer Center | Binding proteins specific for mutant p53 and uses thereof |
| WO2024206274A2 (en) * | 2023-03-27 | 2024-10-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors targeting y220c or r175h mutation in p53 |
| WO2025024648A2 (en) * | 2023-07-25 | 2025-01-30 | Memorial Sloan-Kettering Cancer Center | T cell receptors targeting tp53 hotspot mutations and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003265948B8 (en) | 2002-09-06 | 2009-09-03 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| WO2012129201A1 (en) | 2011-03-22 | 2012-09-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| US11390921B2 (en) * | 2014-04-01 | 2022-07-19 | Adaptive Biotechnologies Corporation | Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs) |
| IL290655B2 (en) | 2014-05-29 | 2024-05-01 | Us Health | Anti-human papillomavirus 16 E7 T-cell chelates |
| CA3080274A1 (en) * | 2017-09-29 | 2019-04-04 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods of isolating t cells having antigenic specificity for a p53 cancer-specific mutation |
| EA202090757A1 (ru) * | 2017-09-29 | 2020-08-21 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | T-КЛЕТОЧНЫЕ РЕЦЕПТОРЫ, РАСПОЗНАЮЩИЕ МУТАНТНЫЙ p53 |
| US20220175899A1 (en) * | 2019-04-11 | 2022-06-09 | The Board Of Trustees Of The Leland Stanford Junior University | Cytotoxic t lymphocytes specific for mutated forms of epidermal growth factor receptor for use in treating cancer |
| CA3144070A1 (en) * | 2019-06-27 | 2020-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors recognizing r175h or y220c mutation in p53 |
-
2022
- 2022-05-06 WO PCT/US2022/028066 patent/WO2022236050A1/en not_active Ceased
- 2022-05-06 JP JP2023568469A patent/JP2024517884A/ja active Pending
- 2022-05-06 US US18/289,596 patent/US20240254190A1/en active Pending
- 2022-05-06 CN CN202280047288.0A patent/CN117957245A/zh active Pending
- 2022-05-06 CA CA3217263A patent/CA3217263A1/en active Pending
- 2022-05-06 EP EP22726335.7A patent/EP4334340A1/en active Pending
- 2022-05-06 KR KR1020237041691A patent/KR20240016288A/ko active Pending
- 2022-05-06 AU AU2022268998A patent/AU2022268998A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7391015B2 (ja) | Ｐ５３がん特異的変異に対して抗原特異性を有するｔ細胞を単離する方法 | |
| CN110809716B (zh) | 基于hla的方法和组合物及其用途 | |
| JP2021536435A (ja) | 核酸とｃａｒ修飾免疫細胞とを含む治療薬およびその使用 | |
| TWI908730B (zh) | 識別p53中之r175h或y220c突變之t細胞受體 | |
| CN105331585A (zh) | 携带pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞 | |
| WO2020259541A1 (zh) | 一种用于肿瘤治疗的嵌合抗原受体t淋巴细胞及其制备方法与应用 | |
| CN105802909A (zh) | 具有her2特异性tcr的t细胞制备物及其用途 | |
| CN111892661A (zh) | 一种嵌合抗原受体及其在制备治疗肿瘤的产品中的应用 | |
| JPWO2020264269A5 (https=) | ||
| WO2026007776A1 (zh) | 连续杀伤能力增强的工程化til细胞及其应用 | |
| CN111875708A (zh) | 一种嵌合抗原受体t淋巴细胞及其在制备治疗实体肿瘤的产品中的应用 | |
| JPWO2020097393A5 (https=) | ||
| JPWO2020243719A5 (https=) | ||
| CN107475275A (zh) | 嵌合抗原受体及其表达基因、双抗原调节的嵌合抗原受体修饰的t细胞及其应用 | |
| JPWO2022236050A5 (https=) | ||
| JP2017536821A (ja) | 抗サイログロブリンｔ細胞レセプター | |
| US20210213121A1 (en) | Neoantigen targeting dna vaccine for combination therapy | |
| CN110464840A (zh) | 一种肿瘤疫苗的制备方法及使用该方法制备的肿瘤疫苗 | |
| CN117777271A (zh) | 一种t细胞受体(tcr)及其用途 | |
| CN106467576A (zh) | 一种抗体融合蛋白及其制备方法与应用 | |
| WO2024216669A1 (zh) | 具有多种免疫调节因子的增强型溶瘤病毒及其制备方法和应用 | |
| CN116751303B (zh) | 一种抗鸟苷酸环化酶2c的纳米抗体及其应用 | |
| JP2024535781A (ja) | 抗原結合タンパク質およびその使用 | |
| CN117777270A (zh) | 一种t细胞受体(tcr)及其用途 | |
| JPWO2022051449A5 (https=) |